GSK sees blockbuster potential in targeted cancer therapy after promising early data
British drugmaker GSK's experimental targeted cancer drug Mo-rez has blockbuster potential, its head of oncology research has told reporters, after early
April 12, 2026
Trial set for Overland Park man accused of stabbing captain on Hawaii snorkel tour
Kansas City man accused of high-speed chase in stolen SUV, fleeing into floodwater
Romanian man sentenced to 4 years in prison for swatting spree targeting dozens of US officials
Trump says that he's is weighing reducing American troop presence in Germany after Iran fued
Supreme Court ruling on race-based redistricting prompts quick action in some states
Wall Street ends mixed ahead of big tech earnings
Carvana's first-quarter profit rises on used-car demand
George Pickens signs $27.3 million franchise tag with Cowboys, opening door for offseason work